12 results for author:"Wetterholm A." in Literature citations
Results Customize
› Repeat search in UniProtKB (3)
| Cysteinyl leukotriene signaling aggravates myocardial hypoxia in experimental atherosclerotic heart disease. Nobili E., Salvado M.D., Folkersen L., Castiglioni L., Kastrup J., Wetterholm A., Tremoli E., Hansson G.K., Sironi L., Haeggstrom J.Z. et al. PLoS ONE 7:e41786-e41786(2012) · Mapped (13) |
| Pre-steady-state kinetic characterization of thiolate anion formation in human leukotriene C(4) synthase. Rinaldo-Matthis A., Ahmad S., Wetterholm A., Lachmann P., Morgenstern R., Haeggstrom J.Z. Biochemistry 51:848-856(2012) · Mapped (2) |
| Arginine 104 is a key catalytic residue in leukotriene C4 synthase. Rinaldo-Matthis A., Wetterholm A., Martinez Molina D., Holm J., Niegowski D., Ohlson E., Nordlund P., Morgenstern R., Haeggstrom J.Z. J. Biol. Chem. 285:40771-40776(2010) · Mapped (2) |
| High-level expression, purification, and crystallization of recombinant rat leukotriene C(4) synthase from the yeast Pichia pastoris. Wetterholm A., Martinez Molina D., Nordlund P., Eshaghi S., Haeggstrom J.Z. Protein Expr. Purif. 60:1-6(2008) · Mapped (2) |
| Structural basis for synthesis of inflammatory mediators by human leukotriene C4 synthase. Martinez Molina D., Wetterholm A., Kohl A., McCarthy A.A., Niegowski D., Ohlson E., Hammarberg T., Eshaghi S., Haeggstroem J.Z., Nordlund P. |
| Expression of 5-lipoxygenase and leukotriene A4 hydrolase in human atherosclerotic lesions correlates with symptoms of plaque instability. Qiu H., Gabrielsen A., Agardh H.E., Wan M., Wetterholm A., Wong C.H., Hedin U., Swedenborg J., Hansson G.K., Samuelsson B. et al. Proc. Natl. Acad. Sci. U.S.A. 103:8161-8166(2006) · Mapped (24) |
| Donepezil in patients with severe Alzheimer's disease: double-blind, parallel-group, placebo-controlled study. Winblad B., Kilander L., Eriksson S., Minthon L., Batsman S., Wetterholm A.L., Jansson-Blixt C., Haglund A. Lancet 367:1057-1065(2006) · Mapped (2) |
| Leukotriene A4 hydrolase: mapping of a henicosapeptide involved in mechanism-based inactivation. Mueller M.J., Wetterholm A., Blomster M., Jornvall H., Samuelsson B., Haeggstrom J.Z. Proc. Natl. Acad. Sci. U.S.A. 92:8383-8387(1995) · UniProtKB (1) |
| Leukotriene A4 hydrolase: a zinc metalloenzyme. Haeggstroem J.Z., Wetterholm A., Shapiro R., Vallee B.L., Samuelsson B. Biochem. Biophys. Res. Commun. 172:965-970(1990) · UniProtKB (1) |
| Recombinant mouse leukotriene A4 hydrolase: a zinc metalloenzyme with dual enzymatic activities. Wetterholm A., Medina J.F., Radmark O., Shapiro R., Haeggstrom J.Z., Vallee B.L., Samuelsson B. Biochim. Biophys. Acta 1080:96-102(1991) · Mapped (1) |
| Leukotriene A4 hydrolase: determination of the three zinc-binding ligands by site-directed mutagenesis and zinc analysis. Medina J.F., Wetterholm A., Raadmark O., Shapiro R., Haeggstroem J.Z., Vallee B.L., Samuelsson B. Proc. Natl. Acad. Sci. U.S.A. 88:7620-7624(1991) · UniProtKB (2) |
| Leukotriene A4 hydrolase: abrogation of the peptidase activity by mutation of glutamic acid-296. Wetterholm A., Medina J.F., Raadmark O., Shapiro R., Haeggstroem J.Z., Vallee B.L., Samuelsson B. Proc. Natl. Acad. Sci. U.S.A. 89:9141-9145(1992) · UniProtKB (1) |